Brigham and Women's Hospital, United States.
Dr. Panupong (Ben) Hansrivijit, MD, is a dedicated nephrology fellow at Brigham and Women’s Hospital/Massachusetts General Hospital, Boston, MA. With a stellar academic background, including an MD with first-class honors from Chulalongkorn University, Dr. Hansrivijit focuses on advancing care for kidney-related conditions. His clinical expertise spans chronic kidney disease, dialysis, and kidney transplantation, alongside a robust research portfolio in nephrology and public health.
Profile
Google Scholar
🎓 Education
Dr. Panupong Hansrivijit is a nephrology fellow at Brigham and Women’s Hospital/Massachusetts General Hospital (2022–2026) and a Master of Public Health candidate at Harvard T.H. Chan School of Public Health (2023–2025). He completed his Internal Medicine Residency at UPMC Harrisburg (2019–2022) and earned his MD with First Class Honors from Chulalongkorn University, Thailand (2016). Dr. Hansrivijit is committed to advancing nephrology and public health through patient care and research.
🏥 Experience
Dr. Panupong Hansrivijit is a dedicated nephrology fellow at Brigham and Women’s Hospital/Massachusetts General Hospital (2022–2026), specializing in kidney care, dialysis, and transplant evaluations. He previously honed his clinical and research expertise during his Internal Medicine Residency at UPMC Harrisburg (2019–2022) and built a strong foundation in patient care as an Internal Medicine Intern at Thammasat University Hospital (2016–2019). Dr. Hansrivijit is passionate about advancing nephrology through clinical excellence and research innovation.
🔬 Research Interests
Chronic kidney disease
Dialysis and dialysis access
Kidney transplantation
Acute kidney injury
Nephrotic syndrome
Hypertension
Pharmaco-epidemiology
🏆 Awards
American Board of Internal Medicine Certification (2022–2032)
Medical License (Massachusetts, 2022–2025)
📚 Selected Publications
Utilization Trends of Tirzepatide, Glucose-Lowering Medications, and Anti-Obesity Medications in Patients with CKD with and without Type 2 Diabetes: SA-PO327
Journal of the American Society of Nephrology, 35 (10S), 10.1681, 2024
Co-authored with J. Ortega-Montiel, D.J. Wexler, E. Patorno, and J.M. Paik, this study explores medication trends in patients with chronic kidney disease (CKD) and type 2 diabetes.
1403-P: Prescribing Trends of Glucose-Lowering Medications among Adult Kidney Transplant Recipients with Type 2 Diabetes—A US Population-Based Cohort Study
Diabetes, 73 (Supplement_1), 2024
In this population-based study, Dr. Hansrivijit, along with collaborators E. Patorno, D.J. Wexler, R. Abdi, and J.M. Paik, examines trends in glucose-lowering medication prescriptions among kidney transplant recipients.
Improvement of Calcinosis Cutis With Sodium Thiosulfate Infusion in a Peritoneal Dialysis Patient: SA-PO338
Journal of the American Society of Nephrology, 33 (11S), 697-698, 2022
A study co-authored with V.S. Iyer, highlighting the therapeutic effect of sodium thiosulfate in treating calcinosis cutis in a peritoneal dialysis patient.
Re: Incidence and Characteristics of Kidney Stones in Patients on Ketogenic Diet: A Systematic Review and Meta-Analysis
Journal of Urology, 207 (2), 462-463, 2022
Dr. Hansrivijit contributed to a meta-analysis investigating kidney stone incidences in patients following a ketogenic diet.
Hyperuricemia is Associated With Increased Mortality in Heart Failure Patients With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis
This study investigates the link between hyperuricemia and mortality risk in heart failure patients with preserved ejection fraction.